Yargesa Capsule
Product Images NDC 42799-709

2 FDA label images from Edenbridge Pharmaceuticals Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Yargesa (NDC 42799-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edenbridge Pharmaceuticals Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Miglustat Structure)

Structure (Miglustat Structure)
Chemical structure of miglustat, the active ingredient in Yargesa 100 mg capsules. The diagram shows a six-membered ring with nitrogen and multiple hydroxyl groups, along with methyl substituents, illustrating the molecular arrangement of this oral human prescription drug.*
FDA Label Image

15ct-carton (Yargesa 15 Count Carton)

15ct-carton (Yargesa 15 Count Carton)
The image shows the packaging label for Yargesa 100 mg capsules containing miglustat. It is for oral use and labeled as Rx only. The package contains 15 unit-dose capsules. The label includes active and inactive ingredient information, storage instructions, manufacturer details (Edenbridge Pharmaceuticals LLC), and a barcode. The design features blue and white colors with orange highlights for the strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.